500.000 people. The number of people who have died from COVID-19 in the United States has passed a number that once seemed unthinkable: Half a million people in this country have died from COVID 19. Losing half a million lives to a pandemic was unimaginable when the first few people died of COVID-19 in February 2020.
Now, a year later, it's easy to forget how suddenly the pandemic upended our lives, and how it impacted all of us, including the medical community. And while the pandemic isn't over yet, and the death toll keeps on climbing, we may slowly allow ourselves to look back on 2020 and ask the difficult questions:
-What will it take to finally halt the spread of the SAR-CoV-2 virus, the virus that causes Covid-19 here, and around the world?
-Will we still be wearing masks in 2022 – or can we expect that Covid-19 will be mostly gone by the late spring, allowing Americans to resume a relatively normal life?
With all the impact the pandemic has had, upending our lives and the impact on the medical community, one thing comes to mind: It’s the gratitude for our physicians and Healthcare workers, the nurses, the staff in the ICU, and the essential workers: A “Thank You” for all you do and continue to do under such difficult and dangerous conditions, clocking in every day and for being there for the most vulnerable!
Also in this In this episode of Physician’s Weekly:
- Bryant Reyes talks with Joel Gelfand, Professor of Dermatology and Epidemiology at the University of Pennsylvania, Perelman School of Medicine, and Co-Chair of the National Psoriasis Foundation COVID-19 Task Force;
- Paul Schmidt talks with Donna Cryer, the president, and chief executive officer of the Global Liver Institute, about NASH – or Nonalcoholic fatty liver disease;
- And Rachel Giles talks with Kevin McCarthy from the University of Pittsburgh’s Center for Vaccine Research about finding from a recent study published in the February 3, 2021 edition of Science Magazine 
 McCarthy KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, Bain WG, Haidar G, Duprex WP. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021 Feb 3:eabf6950. doi: 10.1126/science.abf6950. Epub ahead of print. PMID: 33536258.